Educational content only. Nothing here is investment advice, a solicitation, or an offer. Ideas are AI-generated. Past performance does not predict future results. Full disclosures →
LIVE Loading pipeline status…

FENC · Fennec Pharmaceuticals Inc. — research history

Complete research history. Every dossier, draft, kill, publish, and lesson the system has produced on FENC. Public so users can audit, AI can re-reference. Live price refreshes every 60s.

2 events · 1 investigation(s) · 0 published idea(s) · 0 lesson(s)

About FENC · Fennec Pharmaceuticals Inc.

Fennec Pharmaceuticals Inc. operates as a commercial stage biopharmaceutical company in the United States. The company's product candidate includes PEDMARK, a formulation of sodium thiosulfate for the prevention of cisplatin-induced ototoxicity pediatric patients. It sells its products through regional pediatric oncology specialists and medical science liaisons. Fennec Pharmaceuticals Inc. has collaboration with Tampa General Hospital Foundation, Inc. for evaluation of clinical utility of sodium thiosulfate injection in reducing the risk of ototoxicity in adolescent, young adult, and adult cancer patients receiving cisplatin-based treatment; and Norgine Pharma UK Limited. The company was formerly known as Adherex Technologies Inc. and changed its name to Fennec Pharmaceuticals Inc. in September 2014. Fennec Pharmaceuticals Inc. was incorporated in 1996 and is based in Research Triangle Park, North Carolina.

IndustryBiotechnologySectorHealthcareEmployees35HQResearch Triangle Park, NC, United StatesWebwww.fennecpharma.com ↗

Live Quote

Chart Signal · 1yr BUY conf 5/5 · score +7
Bear$7.21-30%
Fair$11.38+10.4%
Bull$18.00+74.8%

BUY (score +7) · 12-1 mom 18.0% · RSI 69.8 · above_both · 0.0% from high

Targets blend Wall Street consensus (6 analysts: low $13.00 / mean $15.67 / high $18.00) with chart-derived floors and ceilings.

1-Year Chart · RSI · MACD

Loading 1-year chart…

Research Timeline

Newest first. Each entry shows what stage produced it, the verdict/decision, and the reasoning.

Jun 10, 2026scoutunparseable[insider_cluster_universe] 3 Form 4 filings in last 14 days · at least one open-market P/S trade ver

Stage produced output that could not be parsed as a valid JSON object. ~6h cooldown before retry.

Jun 10, 2026scoutunparseable19 tool calls · 16mdebug ⤴

{"symbol":"FENC","company":"Fennec Pharmaceuticals Inc.","investigation_summary":"Fennec Pharmaceuticals is a commercial-stage specialty pharma with one product, PEDMARK (sodium thiosulfate injection), which prevents cisplatin-induced hearing loss in pediatric cancer patients. The investigation trigger was three Form 4 filings within 14 days — however, all three were director option grants at-the-

For AI Agents

Structured JSON of this page's history is at /api/research/FENC.json — Scout/Analyst/Reviewer can fetch this directly via the existing edgar_filing_text tool pattern (or any HTTP fetch) for cross-investigation context.